ERASE - Impact of COVID-19 on Malaria Control
Launched by DOCTORS WITH AFRICA - CUAMM · Apr 25, 2022
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
1. INTRODUCTION
1.1. Malaria epidemiology and global trends Globally, there were an estimated 241 million malaria cases in 2020 in 85 malaria endemic countries, increasing from 227 million in 2019, with most of this increase coming from countries in the WHO African Region.
Although it still represents a major threat for public health, over the last twenty years tremendous progress has been made on malaria control, averting an estimate of 1.5 billion cases and saving 7.6 million lives. Malaria mortality fell by 60% over the period from 2000 to 2019, especially in Africa, where political co...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: All pregnant women at any gestational age presenting to the Aber Hospitals during the study period both at the emergency department or the Ante-Natal Care (ANC) clinic will be eligible to participate in this study.
- Inclusion criteria will be:
- • •. Pregnancy confirmed by positive urine pregnancy test or intrauterine pregnancy by ultrasound;
- • Provision of informed consent;
- • Agreement to come to the study clinic for any febrile episode or other illness;
- • Plan to deliver in the hospital
- Exclusion Criteria:
- • • Ongoing labor or delivery
- • Non-pregnant subpopulation
- Inclusion criteria for this population will be:
- • microscopically confirmed diagnose of malaria ;
- • provision of informed consent;
- • agreement to avoid antimalarial medications given outside the study protocol;
- • agreement to be re-assessed for parasitemia at day 3 Exclusion Criteria
- • too ill to participate in the study according to clinician judgment
About Doctors With Africa Cuamm
Doctors with Africa - CUAMM is a leading non-governmental organization dedicated to improving healthcare in sub-Saharan Africa through the deployment of medical professionals and targeted health initiatives. With a commitment to promoting health equity, CUAMM conducts clinical trials to advance medical knowledge, enhance treatment protocols, and address pressing health challenges in underserved communities. By collaborating with local health systems and engaging in capacity building, CUAMM aims to deliver sustainable healthcare solutions, ultimately improving health outcomes for vulnerable populations across the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials